Compound serving as thyroid hormone beta receptor agonist and application thereof
The invention relates to a compound serving as a thyroid hormone beta receptor agonist and application thereof, and further relates to a compound shown in a formula (1) or a pharmaceutically acceptable form of the compound, a pharmaceutical composition containing the compound and a preparation metho...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YANG SHENGSHENG PAN HUALING SHI JINGJING ZHANG ZHENWEI GONG LINPEI ZHAO YISHUANG |
| description | The invention relates to a compound serving as a thyroid hormone beta receptor agonist and application thereof, and further relates to a compound shown in a formula (1) or a pharmaceutically acceptable form of the compound, a pharmaceutical composition containing the compound and a preparation method of the pharmaceutical composition. The compound or the pharmaceutical composition disclosed by the invention can be used for preparing a medicine for preventing, treating or relieving diseases regulated by a thyroid hormone beta receptor. # imgabs0 #
本发明涉及一种作为甲状腺激素β受体激动剂的化合物及其用途，进一步涉及式(1)所示的化合物或其药学上可接受的形式、包含其的药物组合物、及其制备方法。本发明所述的化合物或药物组合物可以用于制备预防、治疗或减轻由甲状腺激素β受体调节的疾病的药物。#imgabs0# |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116836158A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116836158A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116836158A3</originalsourceid><addsrcrecordid>eNqNyzEKwkAQQNFtLES9w3gAiyUY0sqiWAmCfRg3k2QhmVlmR8Hbm8IDWP3mv7W7B5mzvLiDQvpOPAAWsPGjkjoYRWdhgicZglKkbKKAg3AqBrggzHlKES0JL4qUpN-6VY9Tod2vG7e_nB_heqAsLZWMkZisDTfv66aq_bE5Vf88Xxq5OEE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Compound serving as thyroid hormone beta receptor agonist and application thereof</title><source>esp@cenet</source><creator>YANG SHENGSHENG ; PAN HUALING ; SHI JINGJING ; ZHANG ZHENWEI ; GONG LINPEI ; ZHAO YISHUANG</creator><creatorcontrib>YANG SHENGSHENG ; PAN HUALING ; SHI JINGJING ; ZHANG ZHENWEI ; GONG LINPEI ; ZHAO YISHUANG</creatorcontrib><description>The invention relates to a compound serving as a thyroid hormone beta receptor agonist and application thereof, and further relates to a compound shown in a formula (1) or a pharmaceutically acceptable form of the compound, a pharmaceutical composition containing the compound and a preparation method of the pharmaceutical composition. The compound or the pharmaceutical composition disclosed by the invention can be used for preparing a medicine for preventing, treating or relieving diseases regulated by a thyroid hormone beta receptor. # imgabs0 #
本发明涉及一种作为甲状腺激素β受体激动剂的化合物及其用途，进一步涉及式(1)所示的化合物或其药学上可接受的形式、包含其的药物组合物、及其制备方法。本发明所述的化合物或药物组合物可以用于制备预防、治疗或减轻由甲状腺激素β受体调节的疾病的药物。#imgabs0#</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231003&DB=EPODOC&CC=CN&NR=116836158A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231003&DB=EPODOC&CC=CN&NR=116836158A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YANG SHENGSHENG</creatorcontrib><creatorcontrib>PAN HUALING</creatorcontrib><creatorcontrib>SHI JINGJING</creatorcontrib><creatorcontrib>ZHANG ZHENWEI</creatorcontrib><creatorcontrib>GONG LINPEI</creatorcontrib><creatorcontrib>ZHAO YISHUANG</creatorcontrib><title>Compound serving as thyroid hormone beta receptor agonist and application thereof</title><description>The invention relates to a compound serving as a thyroid hormone beta receptor agonist and application thereof, and further relates to a compound shown in a formula (1) or a pharmaceutically acceptable form of the compound, a pharmaceutical composition containing the compound and a preparation method of the pharmaceutical composition. The compound or the pharmaceutical composition disclosed by the invention can be used for preparing a medicine for preventing, treating or relieving diseases regulated by a thyroid hormone beta receptor. # imgabs0 #
本发明涉及一种作为甲状腺激素β受体激动剂的化合物及其用途，进一步涉及式(1)所示的化合物或其药学上可接受的形式、包含其的药物组合物、及其制备方法。本发明所述的化合物或药物组合物可以用于制备预防、治疗或减轻由甲状腺激素β受体调节的疾病的药物。#imgabs0#</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyzEKwkAQQNFtLES9w3gAiyUY0sqiWAmCfRg3k2QhmVlmR8Hbm8IDWP3mv7W7B5mzvLiDQvpOPAAWsPGjkjoYRWdhgicZglKkbKKAg3AqBrggzHlKES0JL4qUpN-6VY9Tod2vG7e_nB_heqAsLZWMkZisDTfv66aq_bE5Vf88Xxq5OEE</recordid><startdate>20231003</startdate><enddate>20231003</enddate><creator>YANG SHENGSHENG</creator><creator>PAN HUALING</creator><creator>SHI JINGJING</creator><creator>ZHANG ZHENWEI</creator><creator>GONG LINPEI</creator><creator>ZHAO YISHUANG</creator><scope>EVB</scope></search><sort><creationdate>20231003</creationdate><title>Compound serving as thyroid hormone beta receptor agonist and application thereof</title><author>YANG SHENGSHENG ; PAN HUALING ; SHI JINGJING ; ZHANG ZHENWEI ; GONG LINPEI ; ZHAO YISHUANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116836158A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YANG SHENGSHENG</creatorcontrib><creatorcontrib>PAN HUALING</creatorcontrib><creatorcontrib>SHI JINGJING</creatorcontrib><creatorcontrib>ZHANG ZHENWEI</creatorcontrib><creatorcontrib>GONG LINPEI</creatorcontrib><creatorcontrib>ZHAO YISHUANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YANG SHENGSHENG</au><au>PAN HUALING</au><au>SHI JINGJING</au><au>ZHANG ZHENWEI</au><au>GONG LINPEI</au><au>ZHAO YISHUANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Compound serving as thyroid hormone beta receptor agonist and application thereof</title><date>2023-10-03</date><risdate>2023</risdate><abstract>The invention relates to a compound serving as a thyroid hormone beta receptor agonist and application thereof, and further relates to a compound shown in a formula (1) or a pharmaceutically acceptable form of the compound, a pharmaceutical composition containing the compound and a preparation method of the pharmaceutical composition. The compound or the pharmaceutical composition disclosed by the invention can be used for preparing a medicine for preventing, treating or relieving diseases regulated by a thyroid hormone beta receptor. # imgabs0 #
本发明涉及一种作为甲状腺激素β受体激动剂的化合物及其用途，进一步涉及式(1)所示的化合物或其药学上可接受的形式、包含其的药物组合物、及其制备方法。本发明所述的化合物或药物组合物可以用于制备预防、治疗或减轻由甲状腺激素β受体调节的疾病的药物。#imgabs0#</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116836158A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Compound serving as thyroid hormone beta receptor agonist and application thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A57%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YANG%20SHENGSHENG&rft.date=2023-10-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116836158A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |